| Ten cardiac conditions included in the survey | Responses | ||||
|---|---|---|---|---|---|
| Correct | Incorrect | I don’t Know | |||
| Conditions that require prescription of prophylactic antibiotics according to the AHA guidelines | |||||
| Prosthetic cardiac valves | 61% (225) | 33.5% (123) | 5.2% (19) | ||
| Previous infective endocarditis | 62.1% (228) | 33.8% (124) | 4.1% (15) | ||
| Completely repaired CHDs with prosthetic materials or devices during the first 6 months after the procedure | 55% (202) | 33.8% (124) | 11.2% (41) | ||
| Residual defects after repair of CHDs | 41.4% (152) | 43.1% (158) | 15.5% (57) | ||
| Untreated cyanotic congenital heart disease | 42%(157) | 34.6% (127) | 22.6% (83) | ||
| Use of prosthetic materials for cardiac valve repair | 44.7% (164) | 37.3 (137) | 18% (66) | ||
| Cardiac transplantation recipients who develop cardiac valvulopathy | 54% (200) | 28.1%(103) | 17.4% (64) | ||
| Conditions that do not require prophylactic antibiotics according to the AHA guidelines | |||||
| Repaired CHDs with no residual defects at the site | 70.3 (258) | 8.2% (30) | 21.5% (79) | ||
| Heart murmurs | 70.6 (259) | 6.8% (25) | 22.6% (83) | ||
| Heart failure | 59.9% (220) | 15.8% (58) | 24.3% (89) | ||